SlideShare a Scribd company logo
1 of 21
A Law Enforcement View of
Increasing Abuse of Heroin
Current Levels of Prescription Abuse
Indicate Possible Increased Abuse of
Heroin
Past Year Initiates of Specific Illicit
Drugs among Persons Aged 12 or
Older: 2013
2
Marijuana
Pain Relievers
2,427
1,539
1,180
751
603 601 563
824
169 128
32
Tranquilizers
Ecstasy
Stimulants
Cocaine
Inhalants
LSD
Heroin
Sedatives
PCP
0
500
1,500
1,000
2,000
2,500
3,000
hthttp://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUH
results2013.pdf
Opiate Abusers 19 Times More Likely
to Abuse Heroin
A 2013 report by the Substance Abuse and Mental
Health Services Administration (SAMHSA) shows that
people aged 12 to 49 who had used prescription pain
relievers non-medically were 19 times more likely to
have initiated heroin use recently (within the past 12
months of being interviewed) than others in that age
group (0.39 percent versus 0.02 percent). The report
also shows that four out of five recent heroin initiates
(79.5 percent) had previously used prescription pain
relievers non-medically.
http://www.samhsa.gov/newsroom/advisories/1308215815.aspx
3
DEA REPORTS INCREASE AVAILABILITY
OF HEROIN
• DEA intelligence indicates that South American and Mexican drug
trafficking organizations have exploited this increased demand by
producing heroin with increased purity that is not only more readily
available, but also cheaper. That product enters the United States
primarily across our southwest border and, not surprisingly, the
amount of heroin seized there has increased nearly 300 percent
from 2008 to 2013. During roughly the same time period (2008 to
2010), heroin-related overdose deaths have increased by 45
percent. This disturbing increase may be attributable to increased
purity and a younger, less experienced user population. As the
Administration takes a multifaceted approach to curb the
availability of prescription-based painkillers on the illicit market,
those addicted to opioids who are not seeking medication-assisted
therapy may increasingly turn to cheaper or more easily-obtained
alternatives, such as heroin.
Centers for Disease Control and Prevention, National Center for Health Statistics (accessed
February 11, 2013) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5729a1.htm
http://www.justice.gov/dea/pr/speeches-testimony/2014t/043014t.pdf
DEA DEPUTY ASSISTANT ADMINISTRATOR
Congressional Testimony Indicates Increased Heroin
Use Linked to Prescription Medicine Abuse
According to the most recent National Survey on Drug Use
and Health (NSDUH), there were 335,000 current heroin
users in 2012, more than double the number in 2007
(161,000). The DEA believes the increased heroin use is
driven by many factors, including an increase in the misuse
(e.g., using more than medically indicated or using in a
manner not medically indicated) and abuse (i.e., using in
order to feel the psychoactive effects of the drug) of
prescription psychotherapeutic drugs, specifically opioids.
Increases in heroin purity and availability, the low street cost
of heroin, expanded Mexican Drug Trafficking Organizations’
involvement in the distribution of heroin, and the lack of
public awareness of the risks of heroin use are also
important contributing factors.
http://www.dea.gov/pr/speechestestimony/2014t/042914t.pdf
CDC Reports Links Between Heroin Use and
Prescription Drug Abuse Used in DEA Administrator’s
2014 Congressional Testimony
Recently, the Centers for Disease Control and Prevention (CDC)
reported that 38,329 people died from a drug overdose in the United
States in 2010, the most recent year for which information is available.
Nearly 60 percent of those drug overdose deaths (22,134) involved
prescription drugs. And of those deaths, 75 percent (16,651) involved
an opioid analgesic, also known as prescription painkillers. These
deaths represent not just a statistic, but our family members, friends,
neighbors, and colleagues. Years of over prescribing prescription
painkillers and decreased perception of risk associated with drug use,
particularly opiate abuse, has created too many new addicts. The rates
are alarming: in 2011, 2.1 million Americans abused or were dependent
to opioid pain relievers and 438,000 were addicted to heroin.
Drug Overdose in the United States: Fact Sheet. www.cdc.gov/homeandrecreationalsafety/overdose/facts.html (accessed March. 18, 2014).
Muhuri, et al. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the US. Center for behavioral Health Statistics and QualityData Review. SAMHSA (2013). 2013.
http://www.justice.gov/dea/pr/speeches-testimony/2014t/043014t.pdf
6
Heroin Traffickers Adapting to Opiate
Abusing Population
• DEA intelligence reveals that heroin trafficking
organizations are relocating to areas where
non-medical use of prescription drugs on the
rise. Correspondingly, NFLIS shows an increase
in the heroin cases and reports.
http://www.dea.gov/pr/speeches-testimony/2014t/042914t.pdf
NFLIS Estimates
2008 2009 2010 2011 2012 Jan-June 2013
Heroin Reports 95,879 112,153 110,393 119,765 131,624 74,049
Heroin Cases 73,562 83,535 82,385 88,924 99,830 55,744
Total Reports 1,711,763 1,758,505 1,713,360 1,660,216 1,622,435 770,851
Total Cases 1,290,363 1,297,735 1,274,383 1,218,161 1,189,089 578,034
% Heroin Reports 5.60% 6.38% 6.44% 7.21% 8.11% 9.61%
% Heroin Cases 6.92% 7.95% 8.04% 9.24% 10.72% 12.25%
http://www.dea.gov/pr/speeches-testimony/2014t/042914t.pdf
In NFLIS, a “case” is a law enforcement investigation; a “report’’ is an analysis of an
exhibit pertaining to an investigation. There are typically many reports in a single
case.
US Heroin Seizures
2009 - 2013
http://www.dea.gov/resource-center/dir-ndta-unclass.pdf
Source: National Seizure System
Heroin-related Emergency Department Visits
2007 - 2011
Source: Drug Abuse Warning Network
http://www.dea.gov/resource-center/dir-ndta-unclass.pdf
Heroin Use Among Pain
Patients Prescribed Opioids
Methods
• Retrospective review of 171,061 urine
samples
• All patients prescribed opioids for pain
• Samples evaluated for the presence of
– Heroin metabolite (6-monoacetylmorphine)
– Other illicit drugs
– Non-prescribed medications
– Prescribed medication
Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
Overall Results
• 1.3% of samples tested positive for 6-MAM
• Why is this significant
– Detection time of 6-MAM in urine is up to 24
hours
Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
Ameritox Data on file
Qiao Y et al Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine Org. Biomol. Chem.,
2014,12, 2214-2227
Demographic Analysis
Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
Percentage of samples with other
illicits found
Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
Percentage of samples with a
non-prescribed medication found
Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
Percentage of samples with a
non-prescribed medication found
Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
Heroin mixed with other non-
prescribed or illicit drugs
• 20.3% tested positive for non-prescribed
sedative hypnotic
– 11.7% positive for heroin and sedative-hypnotic
– 4.4% positive for heroin, sedative hypnotic,
synthetic opioid
– 3.1% positive for heroin, sedative hypnotic, and
cocaine
– 1.1% positive for heroin, cocaine, sedative
hypnotic, and synthetic opioid
Ameritox Data on File
Heroin mixed with other
non-prescribed or illicit drugs
• 19.1% tested positive for cocaine
– 11.3% positive for heroin and cocaine
– 3.6% positive for heroin, cocaine, synthetic opioid
– 3.1% positive for heroin, cocaine, and sedative
hypnotic
– 1.1% positive for heroin, cocaine, sedative
hypnotic, and synthetic opioid
Ameritox Data on File
Conclusions
• Samples from patients prescribed opioids
that tested positive for heroin were more
likely to test positive for other illicit drugs,
such as cocaine and marijuana.
• In addition, they were more likely to test
positive for other non-prescribed
medications and negative for medications
that were prescribed.
• Clinicians should consider testing for heroin
use when conducting urine drug screens in
patients prescribed opioids.
Ameritox and PRIUM Hospitality Suite
Located in Piedmont 3 on the 12th Floor
Tuesday, April 7: 9:00 AM– 12:00 PM
Meet with the presenters of the Ameritox Vision Session, “Gateway to Heroin:
Opioids”, and continue the discussion:
– Richard Tucker, former DEA Diversion Control Agent
– Toni Torsch, founder of the Perry Hall, Maryland chapter of GRASP (Grief Recovery After
Substance Passing), and the Daniel Carl Torsch Foundation
Meet the Ameritox Toxicology Specialists: discuss test results, additional Ameritox
offerings, and see where your state ranks for illicit drug use, and the use of
prescription and non-prescription medications from the Ameritox National
Prescription Drug Report.
Wednesday, April 8: 11:30 AM– 1:30 PM
Michael Gavin, President of PRIUM, an Ameritox Solutions Provider.
Meet the Ameritox Toxicology Specialists: discuss test results, additional Ameritox
offerings, and see where your state ranks for illicit drug use, and the use of
prescription and non-prescription medications from the Ameritox National
Prescription Drug Report.

More Related Content

What's hot

What's hot (20)

Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_group
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginleyRx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
 
Web only rx16 len tues_1115_group
Web only rx16 len tues_1115_groupWeb only rx16 len tues_1115_group
Web only rx16 len tues_1115_group
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganRx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
 
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
 
Tx 3 hill shuman_oliver
Tx 3 hill shuman_oliverTx 3 hill shuman_oliver
Tx 3 hill shuman_oliver
 

Similar to Rx15 vi sion_tues_800_ameritox

Cover letter and policy brief FINAL
Cover letter and policy brief FINALCover letter and policy brief FINAL
Cover letter and policy brief FINAL
Brittany Weber
 
Collaborating to Combat Heroin and Opioid Addiction In Arizona
Collaborating to Combat Heroin and Opioid Addiction In Arizona Collaborating to Combat Heroin and Opioid Addiction In Arizona
Collaborating to Combat Heroin and Opioid Addiction In Arizona
Jeff Carpenter
 
Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse
Kelseynarin
 
prescription drug abuse
prescription drug abuseprescription drug abuse
prescription drug abuse
kelseyp6
 
Prescription Drug Abuse in the USA
Prescription Drug Abuse in the USAPrescription Drug Abuse in the USA
Prescription Drug Abuse in the USA
Jack Tonkin
 

Similar to Rx15 vi sion_tues_800_ameritox (20)

Prescription drug monitoring programs are unable to combat overdose, finds study
Prescription drug monitoring programs are unable to combat overdose, finds studyPrescription drug monitoring programs are unable to combat overdose, finds study
Prescription drug monitoring programs are unable to combat overdose, finds study
 
High rates of inappropriate drug use.
High rates of inappropriate drug use.High rates of inappropriate drug use.
High rates of inappropriate drug use.
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
 
4th
4th4th
4th
 
Barbara Krantz
Barbara KrantzBarbara Krantz
Barbara Krantz
 
Cover letter and policy brief FINAL
Cover letter and policy brief FINALCover letter and policy brief FINAL
Cover letter and policy brief FINAL
 
Prescription medication obtainment methods & Misuse.
Prescription medication obtainment methods & Misuse.Prescription medication obtainment methods & Misuse.
Prescription medication obtainment methods & Misuse.
 
Collaborating to Combat Heroin and Opioid Addiction In Arizona
Collaborating to Combat Heroin and Opioid Addiction In Arizona Collaborating to Combat Heroin and Opioid Addiction In Arizona
Collaborating to Combat Heroin and Opioid Addiction In Arizona
 
Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse Contemporary Social Issue Presentation on Prescription Abuse
Contemporary Social Issue Presentation on Prescription Abuse
 
Opioid Addiction: New Approach Gives Hope to Patients Awaiting Treatment
Opioid Addiction: New Approach Gives Hope to Patients Awaiting TreatmentOpioid Addiction: New Approach Gives Hope to Patients Awaiting Treatment
Opioid Addiction: New Approach Gives Hope to Patients Awaiting Treatment
 
prescription drug abuse
prescription drug abuseprescription drug abuse
prescription drug abuse
 
Prescription Drug Use Declining
Prescription Drug Use DecliningPrescription Drug Use Declining
Prescription Drug Use Declining
 
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
 
Prescription Drug Abuse in the USA
Prescription Drug Abuse in the USAPrescription Drug Abuse in the USA
Prescription Drug Abuse in the USA
 
aidslinedec13
aidslinedec13aidslinedec13
aidslinedec13
 
ERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose PatientsERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose Patients
 
CDC researchers see link between opioid misuse, binge drinking.
CDC researchers see link between opioid misuse, binge drinking.CDC researchers see link between opioid misuse, binge drinking.
CDC researchers see link between opioid misuse, binge drinking.
 

More from OPUNITE

Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
OPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
OPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
OPUNITE
 

More from OPUNITE (20)

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 

Recently uploaded

💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
Sheetaleventcompany
 
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetOzhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Deny Daniel
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetsurat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh
 
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetTirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
mahaiklolahd
 
Malda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Malda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMalda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Malda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Bihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Call Girl in Indore 8827247818 {Low Price}👉 Nitya Indore Call Girls * ITRG...
Call Girl in Indore 8827247818 {Low Price}👉   Nitya Indore Call Girls  * ITRG...Call Girl in Indore 8827247818 {Low Price}👉   Nitya Indore Call Girls  * ITRG...
Call Girl in Indore 8827247818 {Low Price}👉 Nitya Indore Call Girls * ITRG...
mahaiklolahd
 

Recently uploaded (20)

💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
 
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetOzhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance PaymentsEscorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetsurat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girlKolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
Kolkata Call Girls Miss Inaaya ❤️ at @30% discount Everyday Call girl
 
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetTirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Tirupati Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
 
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur RajasthanJaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
 
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
 
Malda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Malda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMalda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Malda Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thrissur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
 
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dhanbad Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Bihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bihar Sharif Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girl in Indore 8827247818 {Low Price}👉 Nitya Indore Call Girls * ITRG...
Call Girl in Indore 8827247818 {Low Price}👉   Nitya Indore Call Girls  * ITRG...Call Girl in Indore 8827247818 {Low Price}👉   Nitya Indore Call Girls  * ITRG...
Call Girl in Indore 8827247818 {Low Price}👉 Nitya Indore Call Girls * ITRG...
 

Rx15 vi sion_tues_800_ameritox

  • 1. A Law Enforcement View of Increasing Abuse of Heroin Current Levels of Prescription Abuse Indicate Possible Increased Abuse of Heroin
  • 2. Past Year Initiates of Specific Illicit Drugs among Persons Aged 12 or Older: 2013 2 Marijuana Pain Relievers 2,427 1,539 1,180 751 603 601 563 824 169 128 32 Tranquilizers Ecstasy Stimulants Cocaine Inhalants LSD Heroin Sedatives PCP 0 500 1,500 1,000 2,000 2,500 3,000 hthttp://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUH results2013.pdf
  • 3. Opiate Abusers 19 Times More Likely to Abuse Heroin A 2013 report by the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that people aged 12 to 49 who had used prescription pain relievers non-medically were 19 times more likely to have initiated heroin use recently (within the past 12 months of being interviewed) than others in that age group (0.39 percent versus 0.02 percent). The report also shows that four out of five recent heroin initiates (79.5 percent) had previously used prescription pain relievers non-medically. http://www.samhsa.gov/newsroom/advisories/1308215815.aspx 3
  • 4. DEA REPORTS INCREASE AVAILABILITY OF HEROIN • DEA intelligence indicates that South American and Mexican drug trafficking organizations have exploited this increased demand by producing heroin with increased purity that is not only more readily available, but also cheaper. That product enters the United States primarily across our southwest border and, not surprisingly, the amount of heroin seized there has increased nearly 300 percent from 2008 to 2013. During roughly the same time period (2008 to 2010), heroin-related overdose deaths have increased by 45 percent. This disturbing increase may be attributable to increased purity and a younger, less experienced user population. As the Administration takes a multifaceted approach to curb the availability of prescription-based painkillers on the illicit market, those addicted to opioids who are not seeking medication-assisted therapy may increasingly turn to cheaper or more easily-obtained alternatives, such as heroin. Centers for Disease Control and Prevention, National Center for Health Statistics (accessed February 11, 2013) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5729a1.htm http://www.justice.gov/dea/pr/speeches-testimony/2014t/043014t.pdf
  • 5. DEA DEPUTY ASSISTANT ADMINISTRATOR Congressional Testimony Indicates Increased Heroin Use Linked to Prescription Medicine Abuse According to the most recent National Survey on Drug Use and Health (NSDUH), there were 335,000 current heroin users in 2012, more than double the number in 2007 (161,000). The DEA believes the increased heroin use is driven by many factors, including an increase in the misuse (e.g., using more than medically indicated or using in a manner not medically indicated) and abuse (i.e., using in order to feel the psychoactive effects of the drug) of prescription psychotherapeutic drugs, specifically opioids. Increases in heroin purity and availability, the low street cost of heroin, expanded Mexican Drug Trafficking Organizations’ involvement in the distribution of heroin, and the lack of public awareness of the risks of heroin use are also important contributing factors. http://www.dea.gov/pr/speechestestimony/2014t/042914t.pdf
  • 6. CDC Reports Links Between Heroin Use and Prescription Drug Abuse Used in DEA Administrator’s 2014 Congressional Testimony Recently, the Centers for Disease Control and Prevention (CDC) reported that 38,329 people died from a drug overdose in the United States in 2010, the most recent year for which information is available. Nearly 60 percent of those drug overdose deaths (22,134) involved prescription drugs. And of those deaths, 75 percent (16,651) involved an opioid analgesic, also known as prescription painkillers. These deaths represent not just a statistic, but our family members, friends, neighbors, and colleagues. Years of over prescribing prescription painkillers and decreased perception of risk associated with drug use, particularly opiate abuse, has created too many new addicts. The rates are alarming: in 2011, 2.1 million Americans abused or were dependent to opioid pain relievers and 438,000 were addicted to heroin. Drug Overdose in the United States: Fact Sheet. www.cdc.gov/homeandrecreationalsafety/overdose/facts.html (accessed March. 18, 2014). Muhuri, et al. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the US. Center for behavioral Health Statistics and QualityData Review. SAMHSA (2013). 2013. http://www.justice.gov/dea/pr/speeches-testimony/2014t/043014t.pdf 6
  • 7. Heroin Traffickers Adapting to Opiate Abusing Population • DEA intelligence reveals that heroin trafficking organizations are relocating to areas where non-medical use of prescription drugs on the rise. Correspondingly, NFLIS shows an increase in the heroin cases and reports. http://www.dea.gov/pr/speeches-testimony/2014t/042914t.pdf
  • 8. NFLIS Estimates 2008 2009 2010 2011 2012 Jan-June 2013 Heroin Reports 95,879 112,153 110,393 119,765 131,624 74,049 Heroin Cases 73,562 83,535 82,385 88,924 99,830 55,744 Total Reports 1,711,763 1,758,505 1,713,360 1,660,216 1,622,435 770,851 Total Cases 1,290,363 1,297,735 1,274,383 1,218,161 1,189,089 578,034 % Heroin Reports 5.60% 6.38% 6.44% 7.21% 8.11% 9.61% % Heroin Cases 6.92% 7.95% 8.04% 9.24% 10.72% 12.25% http://www.dea.gov/pr/speeches-testimony/2014t/042914t.pdf In NFLIS, a “case” is a law enforcement investigation; a “report’’ is an analysis of an exhibit pertaining to an investigation. There are typically many reports in a single case.
  • 9. US Heroin Seizures 2009 - 2013 http://www.dea.gov/resource-center/dir-ndta-unclass.pdf Source: National Seizure System
  • 10. Heroin-related Emergency Department Visits 2007 - 2011 Source: Drug Abuse Warning Network http://www.dea.gov/resource-center/dir-ndta-unclass.pdf
  • 11. Heroin Use Among Pain Patients Prescribed Opioids
  • 12. Methods • Retrospective review of 171,061 urine samples • All patients prescribed opioids for pain • Samples evaluated for the presence of – Heroin metabolite (6-monoacetylmorphine) – Other illicit drugs – Non-prescribed medications – Prescribed medication Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
  • 13. Overall Results • 1.3% of samples tested positive for 6-MAM • Why is this significant – Detection time of 6-MAM in urine is up to 24 hours Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014 Ameritox Data on file Qiao Y et al Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine Org. Biomol. Chem., 2014,12, 2214-2227
  • 14. Demographic Analysis Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
  • 15. Percentage of samples with other illicits found Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
  • 16. Percentage of samples with a non-prescribed medication found Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
  • 17. Percentage of samples with a non-prescribed medication found Heroin Use Among Pain Patients Prescribed Opioids Pain Week 2014
  • 18. Heroin mixed with other non- prescribed or illicit drugs • 20.3% tested positive for non-prescribed sedative hypnotic – 11.7% positive for heroin and sedative-hypnotic – 4.4% positive for heroin, sedative hypnotic, synthetic opioid – 3.1% positive for heroin, sedative hypnotic, and cocaine – 1.1% positive for heroin, cocaine, sedative hypnotic, and synthetic opioid Ameritox Data on File
  • 19. Heroin mixed with other non-prescribed or illicit drugs • 19.1% tested positive for cocaine – 11.3% positive for heroin and cocaine – 3.6% positive for heroin, cocaine, synthetic opioid – 3.1% positive for heroin, cocaine, and sedative hypnotic – 1.1% positive for heroin, cocaine, sedative hypnotic, and synthetic opioid Ameritox Data on File
  • 20. Conclusions • Samples from patients prescribed opioids that tested positive for heroin were more likely to test positive for other illicit drugs, such as cocaine and marijuana. • In addition, they were more likely to test positive for other non-prescribed medications and negative for medications that were prescribed. • Clinicians should consider testing for heroin use when conducting urine drug screens in patients prescribed opioids.
  • 21. Ameritox and PRIUM Hospitality Suite Located in Piedmont 3 on the 12th Floor Tuesday, April 7: 9:00 AM– 12:00 PM Meet with the presenters of the Ameritox Vision Session, “Gateway to Heroin: Opioids”, and continue the discussion: – Richard Tucker, former DEA Diversion Control Agent – Toni Torsch, founder of the Perry Hall, Maryland chapter of GRASP (Grief Recovery After Substance Passing), and the Daniel Carl Torsch Foundation Meet the Ameritox Toxicology Specialists: discuss test results, additional Ameritox offerings, and see where your state ranks for illicit drug use, and the use of prescription and non-prescription medications from the Ameritox National Prescription Drug Report. Wednesday, April 8: 11:30 AM– 1:30 PM Michael Gavin, President of PRIUM, an Ameritox Solutions Provider. Meet the Ameritox Toxicology Specialists: discuss test results, additional Ameritox offerings, and see where your state ranks for illicit drug use, and the use of prescription and non-prescription medications from the Ameritox National Prescription Drug Report.

Editor's Notes

  1. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings